Skip to content
10-K

Annual Report

TARSUS PHARMACEUTICALS, INC. TARS

0001819790-26-000019

← back to feed
Filed
Feb 23, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 17, 2026 42.56M sh
Shares Diluted FY 2025 · Dec 31, 2025 41.78M sh
Shares Diluted FY 2025 · Dec 31, 2024 37.6M sh
Shares Diluted FY 2025 · Dec 31, 2023 29.38M sh
Capex FY 2025 · Dec 31, 2025 $9.86M
Capex FY 2025 · Dec 31, 2024 $1.57M
Capex FY 2025 · Dec 31, 2023 $1.5M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$12.45M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$83.03M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$117.49M
Long Term Debt FY 2025 · Dec 31, 2025 $72.44M
Long Term Debt FY 2025 · Dec 31, 2024 $71.85M
Cash And Equivalents FY 2025 · Dec 31, 2025 $183.64M
Cash And Equivalents FY 2025 · Dec 31, 2024 $94.82M
Stockholders Equity FY 2025 · Dec 31, 2025 $343.43M
Stockholders Equity FY 2025 · Dec 31, 2024 $224.53M
Stockholders Equity FY 2025 · Dec 31, 2023 $196.99M
Stockholders Equity FY 2025 · Dec 31, 2022 $192.9M
Current Liabilities FY 2025 · Dec 31, 2025 $135.7M
Current Liabilities FY 2025 · Dec 31, 2024 $80.61M
Total Liabilities FY 2025 · Dec 31, 2025 $218.73M
Total Liabilities FY 2025 · Dec 31, 2024 $152.46M
Current Assets FY 2025 · Dec 31, 2025 $522.78M
Current Assets FY 2025 · Dec 31, 2024 $356.71M
Total Assets FY 2025 · Dec 31, 2025 $562.16M
Total Assets FY 2025 · Dec 31, 2024 $376.99M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.59
Eps Diluted FY 2025 · Dec 31, 2024 −$3.07
Eps Diluted FY 2025 · Dec 31, 2023 −$4.62
Eps Basic FY 2025 · Dec 31, 2025 −$1.59
Eps Basic FY 2025 · Dec 31, 2024 −$3.07
Eps Basic FY 2025 · Dec 31, 2023 −$4.62
Sga Expense FY 2025 · Dec 31, 2025 $427.32M
Sga Expense FY 2025 · Dec 31, 2024 $237.31M
Sga Expense FY 2025 · Dec 31, 2023 $108.7M
Rd Expense FY 2025 · Dec 31, 2025 $64.32M
Rd Expense FY 2025 · Dec 31, 2024 $53.39M
Rd Expense FY 2025 · Dec 31, 2023 $50.31M
Net Income FY 2025 · Dec 31, 2025 −$66.42M
Net Income FY 2025 · Dec 31, 2024 −$115.55M
Net Income FY 2025 · Dec 31, 2023 −$135.89M
Operating Income FY 2025 · Dec 31, 2025 −$70.97M
Operating Income FY 2025 · Dec 31, 2024 −$120.57M
Operating Income FY 2025 · Dec 31, 2023 −$143.16M
Revenue FY 2025 · Dec 31, 2025 $451.36M
Revenue FY 2025 · Dec 31, 2024 $182.95M
Revenue FY 2025 · Dec 31, 2023 $17.45M